ACT CAPITAL MANAGEMENT, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$2,483,000
-26.2%
2,197,480
-4.0%
3.43%
-27.2%
Q2 2022$3,364,000
-40.2%
2,288,200
-6.9%
4.70%
-21.0%
Q1 2022$5,630,000
-17.6%
2,458,600
-1.0%
5.96%
+20.6%
Q4 2021$6,830,000
-53.9%
2,483,500
+0.6%
4.94%
-35.6%
Q3 2021$14,805,000
+23.4%
2,467,500
+0.2%
7.67%
+24.5%
Q2 2021$11,993,0002,462,5006.16%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders